Johnson & Johnson Uncategorized Contracts & Agreements

32 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Johnson & Johnson Description of Capital Stock and Registered Debt Securities
Johnson & Johnson
Pharmaceuticals
NY
2025
Intellectual Property Agreement between Johnson & Johnson and Kenvue Inc. (May 3, 2023)
License Agreements
Johnson & Johnson
Pharmaceuticals
DE
2023
Employee Matters Agreement between Johnson & Johnson and Kenvue Inc. (May 3, 2023)
Separation Agreements
Johnson & Johnson
Pharmaceuticals
DE
2023
Tax Matters Agreement between Johnson & Johnson and Kenvue Inc. (May 3, 2023)
Johnson & Johnson
Pharmaceuticals
DE
2023
Johnson & Johnson Excess Benefit Plan (2022 Restatement)
Retirement Agreements
Johnson & Johnson
Pharmaceuticals
2023
Johnson & Johnson Executive Incentive Plan (Amended as of November 28, 2018)
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
2019
Johnson & Johnson Company Order for Issuance of Notes under Indenture (February 2017)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2017
Transaction Agreement among Cilag Holding AG, Janssen Holding GmbH, Actelion Ltd, and Johnson & Johnson (2017)
Merger Agreements
Johnson & Johnson
Pharmaceuticals
NY
2017
Johnson & Johnson 1.650% Note Due 2035 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson 1.150% Note Due 2028 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson 0.650% Note Due 2024 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson 0.250% Note Due 2022 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson Company Order for Issuance of Euro-Denominated Notes (2016)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2016
Johnson & Johnson Company Order for Issuance of Notes under 1987 Indenture
Note Agreements
Johnson & Johnson
Pharmaceuticals
2016
Amendment to the Excess Benefit Plan of Johnson & Johnson and Affiliates (Effective January 1, 2015)
Retirement Agreements
Johnson & Johnson
Pharmaceuticals
2015
Johnson & Johnson Company Order for Issuance of Notes under 1987 Indenture (2014)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2014
Johnson & Johnson Order for Issuance of Notes under 1987 Indenture (2013)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2013
Johnson & Johnson Offer Letter for Paul Stoffels as Worldwide Chairman, Pharmaceuticals Group and Chief Scientific Officer
Employment Agreements
Johnson & Johnson
Pharmaceuticals
2012
Johnson & Johnson Executive Income Deferral Plan (Amended and Restated Effective January 1, 2010)
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
2012
Accelerated Share Repurchase Agreement between JPMorgan Chase Bank and Janssen Pharmaceutical (June 2012)
Repurchase Agreements
Johnson & Johnson
Pharmaceuticals
NY
2012
Accelerated Share Repurchase Agreement between Goldman, Sachs & Co. and Janssen Pharmaceutical
Repurchase Agreements
Johnson & Johnson
Pharmaceuticals
NY
2012
Johnson & Johnson Amended and Restated Deferred Fee Plan for Directors (as of January 17, 2012)
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2012
Johnson & Johnson Non-Employee Director Compensation Arrangements Effective January 1, 2012
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2011
Johnson & Johnson Non-Employee Director Compensation Arrangements Effective January 1, 2011
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2010
Johnson & Johnson Company Order Establishing Terms of 2.95% and 4.50% Notes Due 2020 and 2040
Note Agreements
Johnson & Johnson
Pharmaceuticals
2010
Johnson & Johnson 2010 Executive and Director Compensation Arrangements
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2010
Johnson & Johnson 2009 Certificates of Long-Term Performance Plan
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2009
Amendment to Excess Benefit Plan of Johnson & Johnson and Affiliated Companies (409A Compliance)
Retirement Agreements
Johnson & Johnson
Pharmaceuticals
2009
Amendment to Johnson & Johnson Excess Savings Plan (409A Compliance Addendum)
Retirement Agreements
Johnson & Johnson
Pharmaceuticals
2009
Amendments to Executive Income Deferral Plan Effective January 1, 2009
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2009
Johnson & Johnson Amendments to Deferred Fee Plan for Directors (Section 409A Compliance)
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2009
Amendment No. 1 to Amended and Restated Agreement and Plan of Merger among Johnson & Johnson, Shelby Merger Sub, Inc., and Guidant Corporation
Merger Agreements
Johnson & Johnson
Pharmaceuticals
2006